Jubilant Ingrevia Limited’s Board of Directors has approved the audited financial results for the fiscal year ended March 31, 2026. The company reported a consolidated net profit after tax of ₹27,791 lakhs and total comprehensive income of ₹29,823 lakhs. The auditor’s report on these results carried an unmodified opinion, affirming the accuracy and fairness of the financial statements.
Jubilant Ingrevia Board Approves Full Year Financials
The Board of Directors of Jubilant Ingrevia Limited convened on May 26, 2026, to review and approve the company’s audited financial results for the quarter and year ended March 31, 2026. The meeting, which commenced at 11:10 a.m. and concluded at 02:30 p.m., saw the board give its nod to both the standalone and consolidated financial statements.
Key Financial Highlights (Consolidated)
For the fiscal year ended March 31, 2026, Jubilant Ingrevia reported a consolidated net profit attributable to owners of the company of ₹27,791 lakhs. The total comprehensive income attributable to owners stood at ₹29,823 lakhs. The company also highlighted its revenue from operations for the year, which reached ₹438,807 lakhs. The auditor’s report on these consolidated financial results, issued by M/s Walker Chandiok & Co. LLP, carried an unmodified opinion.
Standalone Financial Performance
On a standalone basis, the company recorded a net profit for the year ended March 31, 2026, of ₹26,797 lakhs. The total comprehensive income for the standalone entity was ₹26,812 lakhs. Revenue from operations on a standalone basis amounted to ₹413,849 lakhs for the same period. Similar to the consolidated results, the standalone financial results also received an unmodified opinion from the statutory auditors.
Segment Performance Overview
The company’s performance was analyzed across its key segments. For the year ended March 31, 2026:
- Speciality Chemicals: Revenue of ₹213,992 lakhs and profit before tax of ₹41,038 lakhs.
- Nutrition & Health Solutions: Revenue of ₹79,040 lakhs and profit before tax of ₹7,942 lakhs.
- Chemical Intermediates: Revenue of ₹166,798 lakhs and profit before tax of ₹18,911 lakhs.
The report also detailed segment assets and liabilities, with total segment assets for the consolidated entity reaching ₹548,373 lakhs and total segment liabilities at ₹235,751 lakhs as of March 31, 2026.
Key Financial Ratios and Disclosures
The financial results included several key financial ratios. For the year ended March 31, 2026:
- Debt service coverage ratio stood at 4.39 times.
- Interest service coverage ratio was 12.36 times.
- Operating margin was 8.92%.
- Net profit margin was 6.28%.
- Net worth (consolidated) was ₹312,622 lakhs.
- Debt equity ratio was 0.19 times.
- Current ratio was 1.29 times.
The company also disclosed its shareholding structure and other relevant financial information as per regulatory requirements.
Declaration by CFO
In line with regulatory requirements, a declaration was provided by Mr. Varun Gupta, Chief Financial Officer, stating that the statutory auditors have issued an auditor’s report with an unmodified opinion on the audited financial results of the company for the financial year ended March 31, 2026.
The audited financial results, along with the auditor’s report and the CFO’s declaration, will be available on the company’s website, www.jubilantingrevia.com.
Source: BSE
